PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $525,387 | -25.5% | 199,767 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $705,178 | +24.1% | 199,767 | +8.6% | 0.00% | +33.3% |
| Q1 2023 | $568,390 | -26.7% | 183,945 | +0.4% | 0.00% | -25.0% |
| Q4 2022 | $775,232 | +119.0% | 183,270 | +22.8% | 0.00% | +100.0% |
| Q3 2022 | $354,000 | +60.2% | 149,294 | +92.4% | 0.00% | +100.0% |
| Q2 2022 | $221,000 | -15.3% | 77,591 | -14.5% | 0.00% | 0.0% |
| Q1 2022 | $261,000 | -14.4% | 90,731 | -9.5% | 0.00% | 0.0% |
| Q4 2021 | $305,000 | +214.4% | 100,215 | +773.9% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | -63.1% | 11,467 | +192.2% | 0.00% | -50.0% |
| Q3 2016 | $263,000 | -67.0% | 3,925 | -85.3% | 0.00% | -66.7% |
| Q2 2016 | $796,000 | -0.5% | 26,725 | -1.9% | 0.01% | 0.0% |
| Q1 2016 | $800,000 | -65.2% | 27,250 | -7.2% | 0.01% | -68.4% |
| Q4 2015 | $2,301,000 | -14.9% | 29,350 | -18.2% | 0.02% | -13.6% |
| Q3 2015 | $2,704,000 | -34.9% | 35,875 | +0.8% | 0.02% | -42.1% |
| Q2 2015 | $4,156,000 | -49.7% | 35,600 | +1.7% | 0.04% | -45.7% |
| Q1 2015 | $8,264,000 | +108.9% | 35,000 | +67.5% | 0.07% | +118.8% |
| Q4 2014 | $3,956,000 | +92.8% | 20,900 | +143.0% | 0.03% | +88.2% |
| Q3 2014 | $2,052,000 | – | 8,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |